Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

BACKGROUND: The prognosis of patients with extensive-stage small cell lung cancer (SCLC) is poor. Adding an immune checkpoint inhibitor (ICI) to chemotherapy may exert a synergistic effect and improve survival outcomes. However, for treatment-naive extensive-stage SCLC patients, the efficacy of immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bi-Cheng, Xiao, Bo-Ya, Li, Peng-Cheng, Kuang, Bo-Hua, Chen, Wang-Bing, Li, Pin-Dong, Lin, Guo-He, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542505/
https://www.ncbi.nlm.nih.gov/pubmed/33061969
http://dx.doi.org/10.1155/2020/2368164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542505/
https://www.ncbi.nlm.nih.gov/pubmed/33061969
http://dx.doi.org/10.1155/2020/2368164

Ejemplares similares